CompletedNot Applicable

Study to Evaluate Satisfaction After Treatment With Restylane

Canada60 participantsStarted 2021-04-16

Plain-language summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Signed and dated informed consent to participate in the study * Adult women who intend to undergo cheek augmentation Exclusion Criteria: * Subjects presenting with known allergy to HA (hyaluronic acid) filler or amide local anesthetics * Subjects with a previous implant other than HA in or near the intended treatment site * Participation in any other clinical study within three (3) months before treatment

What they're measuring

Assess Treatment With Restylane Volyme and Restylane Lyft Lidocaine Using GAIS

Timeframe: 4 weeks after last treatment, up to 6 weeks

Trial details

NCT IDNCT04638816

SponsorGalderma R&D

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-07-03

Results submitted2022-08-24

View on ClinicalTrials.gov More Cheek Augmentation trials